Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Clinical trial NCT00054288 · COMPLETED

Trial details

NCT number: NCT00054288
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-08-01
Primary completion: 2003-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.